Accumulation of NRF2 inhibits ferroptosis by promoting the expression of antioxidant proteins, such as quinone oxidoreductase 1 and heme oxygenase-1, and ferritin heavy chain 1, while knockdown of NRF2 enhances ferroptosis in HCC cells (172). Here, NFE2L2 is linked to hepatocellular carcinoma.